-
UPDATE: J.P. Morgan raises PO on Texas Roadhouse
Monday, May 7, 2012 - 8:03am | 131Read More...According to a research report this morning, J.P. Morgan raises PO on Texas Roadhouse (NASDAQ: TXRH) from $19 to $20 following a strong 1Q and an overall outperformance. J.P. Morgan stated, “We are updating our model to reflect TXRH 1Q results. Traffic-driven comps are outperforming the rest of...
-
Honeywell Fares Well as J.P. Morgan Raises Estimates
Monday, April 23, 2012 - 8:14am | 101Read More...According to a research report this morning, Honeywell (NYSE: HON) is in the better-than-expected 2Q range and it continues to increase its value. J.P. Morgan stated, “EPS of $1.04 was $0.05 ahead of Consensus with segment profits $0.08 ahead of our model, and results included an additional ~$0.02...
-
UPDATE: J.P. Morgan raises PT on M&T Bank to $92
Tuesday, April 17, 2012 - 8:59am | 98Read More...According to a research report this morning, M&T Bank (NYSE: MTB) finished out 1Q12 with a strong EPS of $1.51, blowing away estimates of $1.46. J.P. Morgan stated, “Overall pre-tax, pre-provision results were in line with expectations, although a much stronger than expected quarter for...
-
J.P. Morgan Maintain Overweight Rating on Albemarle
Tuesday, October 25, 2011 - 7:02am | 72Read More...A report from J.P. Morgan reiterates its Overweight rating on Albemarle (NYSE: ALB). The report states, “Albemarle reported 3Q:11 EPS of $1.28 versus $1.02 in the year-ago quarter, and our forecast of $1.21. The Bloomberg Consensus was $1.18. Our EPS forecast did not reflect the $0...
-
J.P. Morgan Maintains Neutral Rating and $23 PT on Owens-Illinois
Tuesday, October 25, 2011 - 6:46am | 89Read More...A report from J.P. Morgan reiterates its Neutral rating and $23 price target on Owens-Illinois (NYSE: OI). The report states, “Improving execution can partially close the gap; however, we see some structural challenges that need to be considered (e.g. price/cost lags in inflationary environment)...
-
J.P. Morgan Lowers PT On CRM To $130
Friday, August 19, 2011 - 8:23am | 97Read More...J.P. Morgan, citing a strong F2Q12 from the company, is lowering its price target on salesforce.com (NYSE: CRM) from $140 to $130, but is maintaining its Neutral rating on the stock. Says J.P. Morgan, in the report, “CRM reported strong F2Q12 results, posting continued momentum in new business...
-
J.P. Morgan Maintains Neutral Rating On Penske Automotive Group
Friday, July 22, 2011 - 8:35am | 76Read More...According to J.P. Morgan, Penske Automotive Group (NYSE: PAG) Neutral rating is maintained. J.P. Morgan said that it left FY2011 and FY2012 EPS unchanged primarily because we are now penciling higher SG&A. “We continue to expect gross margins of new and used vehicles to decline as inventories...
-
J.P.Morgan Raises 2011E EPS To $4.25 On UnitedHealth Group
Wednesday, July 20, 2011 - 9:15am | 99Read More...According to J.P. Morgan, UnitedHealth Group (NYSE: UNH) reported 2Q EPS at $1.16, about $0.27 ahead of estimate, while ex a potential $0.15 charge we had incorporated, the report would have come in $0.12 ahead. J.P. Morgan said that, much like prior quarters, the upside was mostly on lower...
-
J.P. Morgan Comments on Omnicom Group
Monday, July 18, 2011 - 7:18am | 116Read More...J.P. Morgan has published a research report on Omnicom Group (NYSE: OMC) noting positive Q2 results. In the report, J.P. Morgan commented, "We expect strong revenue growth and positive commentary on the health of the ad industry when Omnicom reports 2Q results on Tuesday, July 19th. We believe...
-
J.P. Morgan Maintains Rating, PT On CTXS
Thursday, May 26, 2011 - 8:31am | 140Read More...J.P. Morgan is maintaining its Neutral rating and $53 price target on Citrix Systems (NASDAQ: CTXS) following the company's recent analyst meeting. According to J.P. Morgan, “We attended CTXS' financial analyst meeting held in conjunction with the company's annual Synergy conference in San...
-
J.P. Morgan Raises PT On VRUS To $200
Tuesday, May 24, 2011 - 7:31am | 224Read More...J.P. Morgan has raised its price target on Pharmasset (NASDAQ: VRUS) from $100 to $200 in light of “Biotech Week”Day 2 and portfolio analysis of the stock. According to J.P. Morgan, “[The change in price target] is based on consistent positive feedback from the Hep C arena and building momentum...
-
J.P. Morgan Raises PT On Tornier
Friday, May 20, 2011 - 7:24am | 95Read More...In a recent report, J.P. Morgan has raised the price target on Tornier N.V. (NASDAQ: TRNX) from $26.00 to $30.00 and reiterated an Overweight rating on the company after J.P. Morgan spent a few days on the road with TRNX. In the report, J.P. Morgan said, "The tone was notably upbeat, as the...
-
Noting 'Robust M&A Backlog and Growth Expectations', J.P.Morgan Raises Earnings Forecast on Evercore Partners (EVR)
Monday, May 2, 2011 - 6:42am | 131Read More...J.P.Morgan raised its earnings forecast on shares of Evercore Partners Inc. Monday (NYSE: NVR) Monday, "based on the robust M&A backlog and growth expectations in investment management revenues." Evercore Partners provides advisory services to multinational corporations on mergers,...
-
J.P. Morgan Raises Price Target for Shares of Qlik Technologies
Friday, April 29, 2011 - 9:09am | 104Read More...J.P. Morgan raised its price target from $32 to $35 on shares of Qlik (QLIK) Technologies. J.P. Morgan cites, "The success of QLIK's strategy to invest for growth is clearly evident from recent top line results, but the outcome of this approach can also be seen elsewhere, as deferred revenue...
-
J.P. Morgan Reports Solid 1Q Earnings for Goodrich (GR)
Monday, April 25, 2011 - 9:59am | 97Read More...J.P. Morgan released a report discussing 1Q Earnings for Goodrich (NYSE: GR) and the implications for future growth. Goodrich posted a solid performance record showing continued growth in the first quarter. Despite earlier cautionary reports due to higher oil prices, aftermarket sales seem to be...

